Full development success rates

Researchers developed techniques to spht a single hver from a cadaver and implant it into two recipients, thus increasing the supply of tissue. This measure originated as a means to reduce the sizes of transplant. The intent was to use the right lobe portion of a full-sized adult hver in a child and the left lobe in an adult. Spht hver transplants approach the success rate of fuh transplants. ... 

The full cost of bringing a new drug to market, as defined above, is clearly higher than the cash outlays spent to discover and develop successful new drugs. It also includes the cash outlays spent on projects that fail. And, it must include the opportunity cost of capital, the rate of interest that dollars invested at a given level of risk must earn in exchange for being tied up in the investment (59,285). 

In comparison to current vaccine R D projects, the number of newly Kcensed vaccines is extremely small. Most newly licensed products are improvements or combinations of existing vaccines real vaccine novelties are very rare. Thus, the chances that a vaccine project in advanced research finally ends up as a vaccine product is minimal and is certainly far below 1%. These low success rates in research inevitably lead to long research phases. Short time intervals of around five years between the first publication or patent application of a new vaccine concept and the start of full development are an extremely short, applied research phase for vaccines. These may be applicable to some veterinary vaccines, for which vaccine... 

Scale-up is the process of developing a plant design from experimental data obtained from a unit many orders of magnitude smaller. This activity is considered successful if the commercial plant produces the product at plaimed rates, for plaimed costs, and of desired quaUty. This step from pilot plant to full-scale operation is perhaps the most precarious of all the phases of developing a new process because the highest expenses ate committed at the stages when the greatest risks occur. 

SASOL has pursued the development of alternative reactors to overcome specific operational difficulties encountered with the fixed-bed and entrained-bed reactors. After several years of attempts to overcome the high catalyst circulation rates and consequent abrasion in the Synthol reactors, a bubbling fluidized-bed reactor 1 m (3.3 ft) in diameter was constructed in 1983. Following successflil testing, SASOL designed and construc ted a full-scale commercial reac tor 5 m (16.4 ft) in diameter. The reactor was successfully commissioned in 1989 and remains in operation. 

Fish partial and full life-cycle test methods have been used successfully for many years to assess the effects of nonendocrine active chemicals (McKim 1977) and more recently to focus on high-priority endocrine disrupters (Tyler et al. 1998 Huet 2000 Lange et al. 2001). In some cases, there may also be a need to measure the potential for chronic effects on amphibians, for which developmental effect test methods are available (Devillers and Exbrayat 1992 Pickford et al. 2003). Again, in line with current knowledge, PNEC assessments should be based on impaired fitness parameters (e.g., reduced rates of fertility, development, or fecundity) and not on molecular or biochemical changes (see Figure 4.3). 

A reaction need not go to completion before the sample enters the detector in FIA (15-20). The extent of reaction will be the same in all samples and standards if constant flow rates and sample volumes are maintained. Successful FIA systems have been used in which the extent of reaction was less than 10%. However, the extent of reaction is surprisingly high for many reactions with residence times less than 30 s. The reaction used for the determination of phosphate is greater than 90% complete in less than 15 s (13) even though the manual method calls for at least 5 min for full color development (2). This extent of reaction was accomplished by heating a portion of the manifold to 50 °C. Greater than 90% of the nitrate in seawater is reduced to nitrite in a cadmium reductor in less than 2 s (11, 12). The reaction of nitrite to form an azo dye is complete in less than 15 s (15). 

Had today s marginal corporate tax rate (34 percent) been in effect at the time the NCEs in DiMasi s study were developed, the net after-tax cash outlay per successful NCE would have been no more than 80.1 million, and the full cost capitalized at a 10 percent cost of capital would be 171 million. At today s tax rate, with a cost of capital decreasing from 14 to 10 percent over the life of the project, the average cost of developing a new drug would be no more than 237 million. 

---